Monica B Sood*

Managing Director at Navjivan Health Service (Navjivan Group), Chandigarh, India

*Corresponding Author: Monica B Sood, Managing Director at Navjivan Health Service (Navjivan Group), Chandigarh, India.

Received: March 31, 2024; Published: May 10, 2024

Abstract

Salivary gland tumors represent a diverse group of neoplasms with varying clinical behaviors and treatment responses. Traditional treatment modalities have often relied on histological classification, which may not fully capture the underlying molecular heterogeneity. This paper explores the utility of genomic profiling, particularly next-generation sequencing (NGS) techniques, in unraveling the molecular landscape of salivary gland tumors. Additionally, it investigates the potential of integrating Ayurvedic therapy with precision medicine approaches based on genomic alterations for personalized treatment strategies.

References

Citation

Citation: Monica B Sood. “Integrating Genomic Profiling and Ayurvedic Therapy for Precision in Salivary Gland Tumors". Acta Scientific Otolaryngology 6.6 (2024): 02-03.

Copyright

Copyright: © 2024 Monica B Sood. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.